nodes	percent_of_prediction	percent_of_DWPC	metapath
Oseltamivir—ABCC4—Methotrexate—lymphatic system cancer	0.171	0.615	CbGbCtD
Oseltamivir—SLC22A8—Methotrexate—lymphatic system cancer	0.107	0.384	CbGbCtD
Oseltamivir—Swelling—Carmustine—lymphatic system cancer	0.0041	0.00568	CcSEcCtD
Oseltamivir—Sinusitis—Fludarabine—lymphatic system cancer	0.00409	0.00566	CcSEcCtD
Oseltamivir—Eye pain—Carmustine—lymphatic system cancer	0.00401	0.00555	CcSEcCtD
Oseltamivir—Arrhythmia—Teniposide—lymphatic system cancer	0.00398	0.00551	CcSEcCtD
Oseltamivir—Injury—Carmustine—lymphatic system cancer	0.00394	0.00545	CcSEcCtD
Oseltamivir—Hepatic failure—Vincristine—lymphatic system cancer	0.00384	0.00532	CcSEcCtD
Oseltamivir—Swelling—Mitoxantrone—lymphatic system cancer	0.00381	0.00528	CcSEcCtD
Oseltamivir—Visual impairment—Fludarabine—lymphatic system cancer	0.00377	0.00522	CcSEcCtD
Oseltamivir—Erythema multiforme—Fludarabine—lymphatic system cancer	0.0037	0.00512	CcSEcCtD
Oseltamivir—Gastrointestinal haemorrhage—Carmustine—lymphatic system cancer	0.00362	0.00501	CcSEcCtD
Oseltamivir—Encephalopathy—Methotrexate—lymphatic system cancer	0.0036	0.00498	CcSEcCtD
Oseltamivir—Anaemia—Teniposide—lymphatic system cancer	0.00358	0.00496	CcSEcCtD
Oseltamivir—Agitation—Teniposide—lymphatic system cancer	0.00356	0.00493	CcSEcCtD
Oseltamivir—Arrhythmia—Fludarabine—lymphatic system cancer	0.00349	0.00484	CcSEcCtD
Oseltamivir—Face oedema—Carmustine—lymphatic system cancer	0.00349	0.00484	CcSEcCtD
Oseltamivir—Anaphylactoid reaction—Mitoxantrone—lymphatic system cancer	0.00348	0.00481	CcSEcCtD
Oseltamivir—Pain in extremity—Vincristine—lymphatic system cancer	0.00345	0.00478	CcSEcCtD
Oseltamivir—Liver disorder—Methotrexate—lymphatic system cancer	0.00339	0.00469	CcSEcCtD
Oseltamivir—Gastrointestinal haemorrhage—Mitoxantrone—lymphatic system cancer	0.00336	0.00466	CcSEcCtD
Oseltamivir—Liver function test abnormal—Carmustine—lymphatic system cancer	0.00334	0.00463	CcSEcCtD
Oseltamivir—Pneumonia—Bleomycin—lymphatic system cancer	0.00321	0.00445	CcSEcCtD
Oseltamivir—Confusional state—Teniposide—lymphatic system cancer	0.00319	0.00441	CcSEcCtD
Oseltamivir—Hypersensitivity—Mechlorethamine—lymphatic system cancer	0.00316	0.00438	CcSEcCtD
Oseltamivir—Anaemia—Fludarabine—lymphatic system cancer	0.00315	0.00436	CcSEcCtD
Oseltamivir—Infection—Teniposide—lymphatic system cancer	0.00314	0.00435	CcSEcCtD
Oseltamivir—Agitation—Fludarabine—lymphatic system cancer	0.00313	0.00433	CcSEcCtD
Oseltamivir—Thrombocytopenia—Teniposide—lymphatic system cancer	0.0031	0.00429	CcSEcCtD
Oseltamivir—Abdominal pain upper—Mitoxantrone—lymphatic system cancer	0.00307	0.00425	CcSEcCtD
Oseltamivir—Hepatotoxicity—Methotrexate—lymphatic system cancer	0.00299	0.00414	CcSEcCtD
Oseltamivir—Cough—Fludarabine—lymphatic system cancer	0.00297	0.00411	CcSEcCtD
Oseltamivir—Convulsion—Fludarabine—lymphatic system cancer	0.00295	0.00408	CcSEcCtD
Oseltamivir—Diarrhoea—Mechlorethamine—lymphatic system cancer	0.00293	0.00406	CcSEcCtD
Oseltamivir—Arthralgia—Fludarabine—lymphatic system cancer	0.0029	0.00401	CcSEcCtD
Oseltamivir—Myalgia—Fludarabine—lymphatic system cancer	0.0029	0.00401	CcSEcCtD
Oseltamivir—Pneumonia—Carmustine—lymphatic system cancer	0.0028	0.00388	CcSEcCtD
Oseltamivir—Confusional state—Fludarabine—lymphatic system cancer	0.0028	0.00388	CcSEcCtD
Oseltamivir—Anaphylactic shock—Fludarabine—lymphatic system cancer	0.00278	0.00385	CcSEcCtD
Oseltamivir—Infection—Fludarabine—lymphatic system cancer	0.00276	0.00382	CcSEcCtD
Oseltamivir—Vomiting—Mechlorethamine—lymphatic system cancer	0.00273	0.00378	CcSEcCtD
Oseltamivir—Nervous system disorder—Fludarabine—lymphatic system cancer	0.00273	0.00377	CcSEcCtD
Oseltamivir—Thrombocytopenia—Fludarabine—lymphatic system cancer	0.00272	0.00377	CcSEcCtD
Oseltamivir—Rash—Mechlorethamine—lymphatic system cancer	0.0027	0.00374	CcSEcCtD
Oseltamivir—Upper respiratory tract infection—Mitoxantrone—lymphatic system cancer	0.0027	0.00374	CcSEcCtD
Oseltamivir—Dermatitis—Mechlorethamine—lymphatic system cancer	0.0027	0.00374	CcSEcCtD
Oseltamivir—Pneumonia—Vincristine—lymphatic system cancer	0.00268	0.00371	CcSEcCtD
Oseltamivir—Pneumonia—Mitoxantrone—lymphatic system cancer	0.00261	0.00361	CcSEcCtD
Oseltamivir—Feeling abnormal—Teniposide—lymphatic system cancer	0.00261	0.00361	CcSEcCtD
Oseltamivir—Gastrointestinal pain—Teniposide—lymphatic system cancer	0.00259	0.00358	CcSEcCtD
Oseltamivir—Bone disorder—Methotrexate—lymphatic system cancer	0.00256	0.00354	CcSEcCtD
Oseltamivir—Nausea—Mechlorethamine—lymphatic system cancer	0.00255	0.00353	CcSEcCtD
Oseltamivir—Musculoskeletal discomfort—Fludarabine—lymphatic system cancer	0.00253	0.00351	CcSEcCtD
Oseltamivir—Jaundice—Mitoxantrone—lymphatic system cancer	0.00253	0.0035	CcSEcCtD
Oseltamivir—Conjunctivitis—Mitoxantrone—lymphatic system cancer	0.00252	0.00349	CcSEcCtD
Oseltamivir—Urticaria—Teniposide—lymphatic system cancer	0.00251	0.00348	CcSEcCtD
Oseltamivir—Herpes simplex—Methotrexate—lymphatic system cancer	0.00251	0.00347	CcSEcCtD
Oseltamivir—Body temperature increased—Teniposide—lymphatic system cancer	0.0025	0.00346	CcSEcCtD
Oseltamivir—Abdominal pain—Teniposide—lymphatic system cancer	0.0025	0.00346	CcSEcCtD
Oseltamivir—Hallucination—Carmustine—lymphatic system cancer	0.00249	0.00345	CcSEcCtD
Oseltamivir—Dyspepsia—Fludarabine—lymphatic system cancer	0.00245	0.00339	CcSEcCtD
Oseltamivir—Hepatic enzyme increased—Methotrexate—lymphatic system cancer	0.00244	0.00338	CcSEcCtD
Oseltamivir—Sinusitis—Mitoxantrone—lymphatic system cancer	0.00243	0.00337	CcSEcCtD
Oseltamivir—Visual impairment—Carmustine—lymphatic system cancer	0.00241	0.00334	CcSEcCtD
Oseltamivir—Gastrointestinal disorder—Fludarabine—lymphatic system cancer	0.0024	0.00332	CcSEcCtD
Oseltamivir—Fatigue—Fludarabine—lymphatic system cancer	0.0024	0.00332	CcSEcCtD
Oseltamivir—Hallucination—Vincristine—lymphatic system cancer	0.00238	0.00329	CcSEcCtD
Oseltamivir—Pain—Fludarabine—lymphatic system cancer	0.00238	0.00329	CcSEcCtD
Oseltamivir—Eye disorder—Carmustine—lymphatic system cancer	0.00234	0.00324	CcSEcCtD
Oseltamivir—Hypersensitivity—Teniposide—lymphatic system cancer	0.00233	0.00323	CcSEcCtD
Oseltamivir—Hepatitis—Mitoxantrone—lymphatic system cancer	0.00233	0.00322	CcSEcCtD
Oseltamivir—Anaemia—Bleomycin—lymphatic system cancer	0.00231	0.0032	CcSEcCtD
Oseltamivir—Feeling abnormal—Fludarabine—lymphatic system cancer	0.00229	0.00317	CcSEcCtD
Oseltamivir—Asthenia—Teniposide—lymphatic system cancer	0.00227	0.00314	CcSEcCtD
Oseltamivir—Arrhythmia—Carmustine—lymphatic system cancer	0.00224	0.0031	CcSEcCtD
Oseltamivir—Cardiac disorder—Vincristine—lymphatic system cancer	0.00222	0.00307	CcSEcCtD
Oseltamivir—Body temperature increased—Fludarabine—lymphatic system cancer	0.0022	0.00304	CcSEcCtD
Oseltamivir—Mental disorder—Carmustine—lymphatic system cancer	0.00219	0.00304	CcSEcCtD
Oseltamivir—Cough—Bleomycin—lymphatic system cancer	0.00218	0.00302	CcSEcCtD
Oseltamivir—Diarrhoea—Teniposide—lymphatic system cancer	0.00216	0.003	CcSEcCtD
Oseltamivir—Mediastinal disorder—Vincristine—lymphatic system cancer	0.00215	0.00298	CcSEcCtD
Oseltamivir—Myalgia—Bleomycin—lymphatic system cancer	0.00213	0.00294	CcSEcCtD
Oseltamivir—Back pain—Carmustine—lymphatic system cancer	0.00211	0.00292	CcSEcCtD
Oseltamivir—Mental disorder—Vincristine—lymphatic system cancer	0.00209	0.0029	CcSEcCtD
Oseltamivir—Arrhythmia—Mitoxantrone—lymphatic system cancer	0.00208	0.00288	CcSEcCtD
Oseltamivir—Confusional state—Bleomycin—lymphatic system cancer	0.00205	0.00284	CcSEcCtD
Oseltamivir—Hypersensitivity—Fludarabine—lymphatic system cancer	0.00205	0.00283	CcSEcCtD
Oseltamivir—Anaphylactic shock—Bleomycin—lymphatic system cancer	0.00204	0.00282	CcSEcCtD
Oseltamivir—Infection—Bleomycin—lymphatic system cancer	0.00202	0.0028	CcSEcCtD
Oseltamivir—Anaemia—Carmustine—lymphatic system cancer	0.00201	0.00279	CcSEcCtD
Oseltamivir—Back pain—Vincristine—lymphatic system cancer	0.00201	0.00279	CcSEcCtD
Oseltamivir—Vomiting—Teniposide—lymphatic system cancer	0.00201	0.00278	CcSEcCtD
Oseltamivir—Agitation—Carmustine—lymphatic system cancer	0.002	0.00277	CcSEcCtD
Oseltamivir—Thrombocytopenia—Bleomycin—lymphatic system cancer	0.00199	0.00276	CcSEcCtD
Oseltamivir—Asthenia—Fludarabine—lymphatic system cancer	0.00199	0.00276	CcSEcCtD
Oseltamivir—Rash—Teniposide—lymphatic system cancer	0.00199	0.00276	CcSEcCtD
Oseltamivir—Dermatitis—Teniposide—lymphatic system cancer	0.00199	0.00276	CcSEcCtD
Oseltamivir—Headache—Teniposide—lymphatic system cancer	0.00198	0.00274	CcSEcCtD
Oseltamivir—Lymphadenopathy—Methotrexate—lymphatic system cancer	0.00196	0.00272	CcSEcCtD
Oseltamivir—Back pain—Mitoxantrone—lymphatic system cancer	0.00196	0.00271	CcSEcCtD
Oseltamivir—Diabetes mellitus—Methotrexate—lymphatic system cancer	0.00193	0.00267	CcSEcCtD
Oseltamivir—Anaemia—Vincristine—lymphatic system cancer	0.00192	0.00266	CcSEcCtD
Oseltamivir—Agitation—Vincristine—lymphatic system cancer	0.00191	0.00265	CcSEcCtD
Oseltamivir—Diarrhoea—Fludarabine—lymphatic system cancer	0.0019	0.00263	CcSEcCtD
Oseltamivir—Convulsion—Carmustine—lymphatic system cancer	0.00189	0.00261	CcSEcCtD
Oseltamivir—Nausea—Teniposide—lymphatic system cancer	0.00188	0.0026	CcSEcCtD
Oseltamivir—Anaemia—Mitoxantrone—lymphatic system cancer	0.00187	0.00259	CcSEcCtD
Oseltamivir—Vertigo—Vincristine—lymphatic system cancer	0.00187	0.00259	CcSEcCtD
Oseltamivir—Hepatic failure—Methotrexate—lymphatic system cancer	0.00187	0.00258	CcSEcCtD
Oseltamivir—Musculoskeletal discomfort—Bleomycin—lymphatic system cancer	0.00186	0.00257	CcSEcCtD
Oseltamivir—Myalgia—Carmustine—lymphatic system cancer	0.00186	0.00257	CcSEcCtD
Oseltamivir—Anxiety—Carmustine—lymphatic system cancer	0.00185	0.00256	CcSEcCtD
Oseltamivir—Convulsion—Vincristine—lymphatic system cancer	0.0018	0.0025	CcSEcCtD
Oseltamivir—Confusional state—Carmustine—lymphatic system cancer	0.00179	0.00248	CcSEcCtD
Oseltamivir—Myalgia—Vincristine—lymphatic system cancer	0.00177	0.00245	CcSEcCtD
Oseltamivir—Visual disturbance—Methotrexate—lymphatic system cancer	0.00177	0.00245	CcSEcCtD
Oseltamivir—Cough—Mitoxantrone—lymphatic system cancer	0.00177	0.00245	CcSEcCtD
Oseltamivir—Infection—Carmustine—lymphatic system cancer	0.00177	0.00245	CcSEcCtD
Oseltamivir—Vomiting—Fludarabine—lymphatic system cancer	0.00177	0.00245	CcSEcCtD
Oseltamivir—Convulsion—Mitoxantrone—lymphatic system cancer	0.00176	0.00243	CcSEcCtD
Oseltamivir—Rash—Fludarabine—lymphatic system cancer	0.00175	0.00243	CcSEcCtD
Oseltamivir—Dermatitis—Fludarabine—lymphatic system cancer	0.00175	0.00242	CcSEcCtD
Oseltamivir—Pain—Bleomycin—lymphatic system cancer	0.00174	0.00241	CcSEcCtD
Oseltamivir—Thrombocytopenia—Carmustine—lymphatic system cancer	0.00174	0.00241	CcSEcCtD
Oseltamivir—Headache—Fludarabine—lymphatic system cancer	0.00174	0.00241	CcSEcCtD
Oseltamivir—Anaphylactoid reaction—Methotrexate—lymphatic system cancer	0.00173	0.0024	CcSEcCtD
Oseltamivir—Arthralgia—Mitoxantrone—lymphatic system cancer	0.00172	0.00239	CcSEcCtD
Oseltamivir—Myalgia—Mitoxantrone—lymphatic system cancer	0.00172	0.00239	CcSEcCtD
Oseltamivir—Anxiety—Mitoxantrone—lymphatic system cancer	0.00172	0.00238	CcSEcCtD
Oseltamivir—Anaphylactic shock—Vincristine—lymphatic system cancer	0.0017	0.00235	CcSEcCtD
Oseltamivir—Infection—Vincristine—lymphatic system cancer	0.00169	0.00234	CcSEcCtD
Oseltamivir—Feeling abnormal—Bleomycin—lymphatic system cancer	0.00168	0.00232	CcSEcCtD
Oseltamivir—Confusional state—Mitoxantrone—lymphatic system cancer	0.00167	0.00231	CcSEcCtD
Oseltamivir—Nervous system disorder—Vincristine—lymphatic system cancer	0.00166	0.00231	CcSEcCtD
Oseltamivir—Thrombocytopenia—Vincristine—lymphatic system cancer	0.00166	0.0023	CcSEcCtD
Oseltamivir—Anaphylactic shock—Mitoxantrone—lymphatic system cancer	0.00165	0.00229	CcSEcCtD
Oseltamivir—Nausea—Fludarabine—lymphatic system cancer	0.00165	0.00229	CcSEcCtD
Oseltamivir—Infection—Mitoxantrone—lymphatic system cancer	0.00164	0.00227	CcSEcCtD
Oseltamivir—Musculoskeletal discomfort—Carmustine—lymphatic system cancer	0.00162	0.00224	CcSEcCtD
Oseltamivir—Thrombocytopenia—Mitoxantrone—lymphatic system cancer	0.00162	0.00224	CcSEcCtD
Oseltamivir—Urticaria—Bleomycin—lymphatic system cancer	0.00162	0.00224	CcSEcCtD
Oseltamivir—Body temperature increased—Bleomycin—lymphatic system cancer	0.00161	0.00223	CcSEcCtD
Oseltamivir—Insomnia—Carmustine—lymphatic system cancer	0.00161	0.00223	CcSEcCtD
Oseltamivir—Skin disorder—Mitoxantrone—lymphatic system cancer	0.00161	0.00222	CcSEcCtD
Oseltamivir—Liver function test abnormal—Methotrexate—lymphatic system cancer	0.00155	0.00214	CcSEcCtD
Oseltamivir—Musculoskeletal discomfort—Vincristine—lymphatic system cancer	0.00155	0.00214	CcSEcCtD
Oseltamivir—Insomnia—Vincristine—lymphatic system cancer	0.00154	0.00213	CcSEcCtD
Oseltamivir—Gastrointestinal disorder—Carmustine—lymphatic system cancer	0.00154	0.00213	CcSEcCtD
Oseltamivir—Pain—Carmustine—lymphatic system cancer	0.00152	0.00211	CcSEcCtD
Oseltamivir—Toxic epidermal necrolysis—Methotrexate—lymphatic system cancer	0.00151	0.00209	CcSEcCtD
Oseltamivir—Musculoskeletal discomfort—Mitoxantrone—lymphatic system cancer	0.00151	0.00209	CcSEcCtD
Oseltamivir—Hypersensitivity—Bleomycin—lymphatic system cancer	0.0015	0.00208	CcSEcCtD
Oseltamivir—Gastrointestinal disorder—Vincristine—lymphatic system cancer	0.00147	0.00203	CcSEcCtD
Oseltamivir—Feeling abnormal—Carmustine—lymphatic system cancer	0.00147	0.00203	CcSEcCtD
Oseltamivir—Fatigue—Vincristine—lymphatic system cancer	0.00146	0.00203	CcSEcCtD
Oseltamivir—Asthenia—Bleomycin—lymphatic system cancer	0.00146	0.00202	CcSEcCtD
Oseltamivir—Dyspepsia—Mitoxantrone—lymphatic system cancer	0.00146	0.00202	CcSEcCtD
Oseltamivir—Gastrointestinal pain—Carmustine—lymphatic system cancer	0.00145	0.00201	CcSEcCtD
Oseltamivir—Pain—Vincristine—lymphatic system cancer	0.00145	0.00201	CcSEcCtD
Oseltamivir—Asthma—Methotrexate—lymphatic system cancer	0.00145	0.00201	CcSEcCtD
Oseltamivir—Fatigue—Mitoxantrone—lymphatic system cancer	0.00143	0.00197	CcSEcCtD
Oseltamivir—Pain—Mitoxantrone—lymphatic system cancer	0.00141	0.00196	CcSEcCtD
Oseltamivir—Body temperature increased—Carmustine—lymphatic system cancer	0.00141	0.00195	CcSEcCtD
Oseltamivir—Abdominal pain—Carmustine—lymphatic system cancer	0.00141	0.00195	CcSEcCtD
Oseltamivir—Gastrointestinal pain—Vincristine—lymphatic system cancer	0.00139	0.00192	CcSEcCtD
Oseltamivir—Feeling abnormal—Mitoxantrone—lymphatic system cancer	0.00136	0.00189	CcSEcCtD
Oseltamivir—Gastrointestinal pain—Mitoxantrone—lymphatic system cancer	0.00135	0.00187	CcSEcCtD
Oseltamivir—Upper respiratory tract infection—Methotrexate—lymphatic system cancer	0.00135	0.00186	CcSEcCtD
Oseltamivir—Body temperature increased—Vincristine—lymphatic system cancer	0.00134	0.00186	CcSEcCtD
Oseltamivir—Abdominal pain—Vincristine—lymphatic system cancer	0.00134	0.00186	CcSEcCtD
Oseltamivir—Urticaria—Mitoxantrone—lymphatic system cancer	0.00131	0.00182	CcSEcCtD
Oseltamivir—Hypersensitivity—Carmustine—lymphatic system cancer	0.00131	0.00181	CcSEcCtD
Oseltamivir—Abdominal pain—Mitoxantrone—lymphatic system cancer	0.00131	0.00181	CcSEcCtD
Oseltamivir—Body temperature increased—Mitoxantrone—lymphatic system cancer	0.00131	0.00181	CcSEcCtD
Oseltamivir—Pneumonia—Methotrexate—lymphatic system cancer	0.0013	0.0018	CcSEcCtD
Oseltamivir—Vomiting—Bleomycin—lymphatic system cancer	0.0013	0.00179	CcSEcCtD
Oseltamivir—Infestation NOS—Methotrexate—lymphatic system cancer	0.00129	0.00179	CcSEcCtD
Oseltamivir—Infestation—Methotrexate—lymphatic system cancer	0.00129	0.00179	CcSEcCtD
Oseltamivir—Rash—Bleomycin—lymphatic system cancer	0.00128	0.00178	CcSEcCtD
Oseltamivir—Dermatitis—Bleomycin—lymphatic system cancer	0.00128	0.00178	CcSEcCtD
Oseltamivir—Stevens-Johnson syndrome—Methotrexate—lymphatic system cancer	0.00128	0.00177	CcSEcCtD
Oseltamivir—Asthenia—Carmustine—lymphatic system cancer	0.00128	0.00177	CcSEcCtD
Oseltamivir—Conjunctivitis—Methotrexate—lymphatic system cancer	0.00126	0.00174	CcSEcCtD
Oseltamivir—Hypersensitivity—Vincristine—lymphatic system cancer	0.00125	0.00173	CcSEcCtD
Oseltamivir—Hepatobiliary disease—Methotrexate—lymphatic system cancer	0.00122	0.00169	CcSEcCtD
Oseltamivir—Epistaxis—Methotrexate—lymphatic system cancer	0.00122	0.00169	CcSEcCtD
Oseltamivir—Hypersensitivity—Mitoxantrone—lymphatic system cancer	0.00122	0.00169	CcSEcCtD
Oseltamivir—Asthenia—Vincristine—lymphatic system cancer	0.00122	0.00169	CcSEcCtD
Oseltamivir—Diarrhoea—Carmustine—lymphatic system cancer	0.00122	0.00168	CcSEcCtD
Oseltamivir—Nausea—Bleomycin—lymphatic system cancer	0.00121	0.00168	CcSEcCtD
Oseltamivir—Asthenia—Mitoxantrone—lymphatic system cancer	0.00119	0.00164	CcSEcCtD
Oseltamivir—Dizziness—Carmustine—lymphatic system cancer	0.00118	0.00163	CcSEcCtD
Oseltamivir—Diarrhoea—Vincristine—lymphatic system cancer	0.00116	0.00161	CcSEcCtD
Oseltamivir—Hepatitis—Methotrexate—lymphatic system cancer	0.00116	0.00161	CcSEcCtD
Oseltamivir—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.00113	0.00157	CcSEcCtD
Oseltamivir—Vomiting—Carmustine—lymphatic system cancer	0.00113	0.00157	CcSEcCtD
Oseltamivir—Dizziness—Vincristine—lymphatic system cancer	0.00112	0.00155	CcSEcCtD
Oseltamivir—Rash—Carmustine—lymphatic system cancer	0.00112	0.00155	CcSEcCtD
Oseltamivir—Dermatitis—Carmustine—lymphatic system cancer	0.00112	0.00155	CcSEcCtD
Oseltamivir—Visual impairment—Methotrexate—lymphatic system cancer	0.00112	0.00155	CcSEcCtD
Oseltamivir—Headache—Carmustine—lymphatic system cancer	0.00111	0.00154	CcSEcCtD
Oseltamivir—Erythema multiforme—Methotrexate—lymphatic system cancer	0.0011	0.00152	CcSEcCtD
Oseltamivir—Eye disorder—Methotrexate—lymphatic system cancer	0.00108	0.0015	CcSEcCtD
Oseltamivir—Vomiting—Vincristine—lymphatic system cancer	0.00108	0.00149	CcSEcCtD
Oseltamivir—Cardiac disorder—Methotrexate—lymphatic system cancer	0.00108	0.00149	CcSEcCtD
Oseltamivir—Rash—Vincristine—lymphatic system cancer	0.00107	0.00148	CcSEcCtD
Oseltamivir—Dermatitis—Vincristine—lymphatic system cancer	0.00107	0.00148	CcSEcCtD
Oseltamivir—Headache—Vincristine—lymphatic system cancer	0.00106	0.00147	CcSEcCtD
Oseltamivir—Nausea—Carmustine—lymphatic system cancer	0.00106	0.00146	CcSEcCtD
Oseltamivir—Vomiting—Mitoxantrone—lymphatic system cancer	0.00105	0.00146	CcSEcCtD
Oseltamivir—Immune system disorder—Methotrexate—lymphatic system cancer	0.00105	0.00145	CcSEcCtD
Oseltamivir—Mediastinal disorder—Methotrexate—lymphatic system cancer	0.00104	0.00145	CcSEcCtD
Oseltamivir—Rash—Mitoxantrone—lymphatic system cancer	0.00104	0.00144	CcSEcCtD
Oseltamivir—Dermatitis—Mitoxantrone—lymphatic system cancer	0.00104	0.00144	CcSEcCtD
Oseltamivir—Headache—Mitoxantrone—lymphatic system cancer	0.00104	0.00143	CcSEcCtD
Oseltamivir—Mental disorder—Methotrexate—lymphatic system cancer	0.00102	0.00141	CcSEcCtD
Oseltamivir—Nausea—Vincristine—lymphatic system cancer	0.00101	0.0014	CcSEcCtD
Oseltamivir—Nausea—Mitoxantrone—lymphatic system cancer	0.000982	0.00136	CcSEcCtD
Oseltamivir—Back pain—Methotrexate—lymphatic system cancer	0.000976	0.00135	CcSEcCtD
Oseltamivir—Anaemia—Methotrexate—lymphatic system cancer	0.000933	0.00129	CcSEcCtD
Oseltamivir—Vertigo—Methotrexate—lymphatic system cancer	0.000907	0.00126	CcSEcCtD
Oseltamivir—Cough—Methotrexate—lymphatic system cancer	0.000881	0.00122	CcSEcCtD
Oseltamivir—Convulsion—Methotrexate—lymphatic system cancer	0.000875	0.00121	CcSEcCtD
Oseltamivir—Arthralgia—Methotrexate—lymphatic system cancer	0.000859	0.00119	CcSEcCtD
Oseltamivir—Myalgia—Methotrexate—lymphatic system cancer	0.000859	0.00119	CcSEcCtD
Oseltamivir—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lymphatic system cancer	0.000853	0.00118	CcSEcCtD
Oseltamivir—Confusional state—Methotrexate—lymphatic system cancer	0.000831	0.00115	CcSEcCtD
Oseltamivir—Anaphylactic shock—Methotrexate—lymphatic system cancer	0.000824	0.00114	CcSEcCtD
Oseltamivir—Infection—Methotrexate—lymphatic system cancer	0.000818	0.00113	CcSEcCtD
Oseltamivir—Nervous system disorder—Methotrexate—lymphatic system cancer	0.000808	0.00112	CcSEcCtD
Oseltamivir—Thrombocytopenia—Methotrexate—lymphatic system cancer	0.000807	0.00112	CcSEcCtD
Oseltamivir—Skin disorder—Methotrexate—lymphatic system cancer	0.0008	0.00111	CcSEcCtD
Oseltamivir—Musculoskeletal discomfort—Methotrexate—lymphatic system cancer	0.000751	0.00104	CcSEcCtD
Oseltamivir—Insomnia—Methotrexate—lymphatic system cancer	0.000745	0.00103	CcSEcCtD
Oseltamivir—Dyspepsia—Methotrexate—lymphatic system cancer	0.000725	0.001	CcSEcCtD
Oseltamivir—Gastrointestinal disorder—Methotrexate—lymphatic system cancer	0.000711	0.000985	CcSEcCtD
Oseltamivir—Fatigue—Methotrexate—lymphatic system cancer	0.00071	0.000983	CcSEcCtD
Oseltamivir—Pain—Methotrexate—lymphatic system cancer	0.000704	0.000975	CcSEcCtD
Oseltamivir—Feeling abnormal—Methotrexate—lymphatic system cancer	0.000679	0.00094	CcSEcCtD
Oseltamivir—Gastrointestinal pain—Methotrexate—lymphatic system cancer	0.000674	0.000933	CcSEcCtD
Oseltamivir—Urticaria—Methotrexate—lymphatic system cancer	0.000654	0.000906	CcSEcCtD
Oseltamivir—Abdominal pain—Methotrexate—lymphatic system cancer	0.000651	0.000902	CcSEcCtD
Oseltamivir—Body temperature increased—Methotrexate—lymphatic system cancer	0.000651	0.000902	CcSEcCtD
Oseltamivir—Hypersensitivity—Methotrexate—lymphatic system cancer	0.000607	0.00084	CcSEcCtD
Oseltamivir—Asthenia—Methotrexate—lymphatic system cancer	0.000591	0.000818	CcSEcCtD
Oseltamivir—Diarrhoea—Methotrexate—lymphatic system cancer	0.000564	0.00078	CcSEcCtD
Oseltamivir—Dizziness—Methotrexate—lymphatic system cancer	0.000545	0.000754	CcSEcCtD
Oseltamivir—Vomiting—Methotrexate—lymphatic system cancer	0.000524	0.000725	CcSEcCtD
Oseltamivir—Rash—Methotrexate—lymphatic system cancer	0.000519	0.000719	CcSEcCtD
Oseltamivir—Dermatitis—Methotrexate—lymphatic system cancer	0.000519	0.000719	CcSEcCtD
Oseltamivir—Headache—Methotrexate—lymphatic system cancer	0.000516	0.000715	CcSEcCtD
Oseltamivir—Nausea—Methotrexate—lymphatic system cancer	0.000489	0.000678	CcSEcCtD
